Constellation Brands
About: Constellation Brands is the largest provider of alcoholic beverages across the beer, wine, and spirits categories in the U.S., generating 80% of revenue from Mexican beer imports under top-selling brands such as Modelo and Corona. The rest of the business includes some remaining wine and spirits brands, categories where the company continue to prune assets in recent years. With its exclusive rights tied to the Mexican beer brands effective only in the U.S., the firm has small revenue exposure to international markets. Constellation owns a 36% stake in no-moat Canopy Growth, a medicinal and recreational cannabis producer in Canada, and has a 50/50 joint venture with glass manufacturer Owens-Illinois in Mexico.
Employees: 10,600
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
5% less first-time investments, than exits
New positions opened: 94 | Existing positions closed: 99
6% less repeat investments, than reductions
Existing positions increased: 487 | Existing positions reduced: 518
2% less funds holding
Funds holding: 1,318 [Q2] → 1,295 (-23) [Q3]
5.65% less ownership
Funds ownership: 86.18% [Q2] → 80.53% (-5.65%) [Q3]
7% less capital invested
Capital invested by funds: $40.4B [Q2] → $37.7B (-$2.71B) [Q3]
42% less call options, than puts
Call options by funds: $395M | Put options by funds: $681M
50% less funds holding in top 10
Funds holding in top 10: 12 [Q2] → 6 (-6) [Q3]
Research analyst outlook
12 Wall Street Analysts provided 1 year price targets over the past 3 months
12 analyst ratings
RBC Capital Nik Modi 21% 1-year accuracy 9 / 43 met price target | 71%upside $293 | Outperform Reiterated | 3 Feb 2025 |
Piper Sandler Michael Lavery 33% 1-year accuracy 19 / 58 met price target | 17%upside $200 | Neutral Downgraded | 3 Feb 2025 |
Needham Gerald Pascarelli 4% 1-year accuracy 1 / 25 met price target | 40%upside $240 | Buy Maintained | 27 Jan 2025 |
Truist Securities Bill Chappell 38% 1-year accuracy 11 / 29 met price target | 11%upside $190 | Hold Maintained | 14 Jan 2025 |
Barclays Lauren Lieberman 43% 1-year accuracy 39 / 90 met price target | 25%upside $214 | Overweight Maintained | 14 Jan 2025 |
Financial journalist opinion
Based on 44 articles about STZ published over the past 30 days









